Disclosed positions

Estimated from their latest filings — positions may have changed since

$5.39M

combined est. value

Stock	Shares	Price	Value	Weight	As of
KYMRKymera Therapeutics, Inc.	47,179	$114.16	$5.39M	100%	2026-07-01

KYMR

Kymera Therapeutics, Inc.

$5.39M

47,179 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 4

Stock	Transaction	Date	~6mo later
KYMRKymera Therapeutics, Inc.	Sell $387.3K · 3,389 sh	2026-07-01	—
KYMRKymera Therapeutics, Inc.	Sell $297.5K · 2,500 sh	2026-06-25	—
KYMRKymera Therapeutics, Inc.	Sell $272.5K · 2,500 sh	2026-06-25	—
KYMRKymera Therapeutics, Inc.	Exercise $105.3K · 5,000 sh	2026-06-25	—
KYMRKymera Therapeutics, Inc.	Sell $247.5K · 2,500 sh	2026-06-22	—
KYMRKymera Therapeutics, Inc.	Exercise $52.6K · 2,500 sh	2026-06-22	—

KYMRSell

2026-07-01 · Kymera Therapeutics, Inc.

$387.3K

—

KYMRSell

2026-06-25 · Kymera Therapeutics, Inc.

$297.5K

—

KYMRSell

2026-06-25 · Kymera Therapeutics, Inc.

$272.5K

—

KYMRExercise

2026-06-25 · Kymera Therapeutics, Inc.

$105.3K

—

KYMRSell

2026-06-22 · Kymera Therapeutics, Inc.

$247.5K

—

KYMRExercise

2026-06-22 · Kymera Therapeutics, Inc.

$52.6K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.